Navigation Links
Treating eye diseases with anti-VEGF therapies may have side effects
Date:1/11/2013

Rockville, MD A new Investigative Ophthalmology & Visual Science (IOVS) article reveals that increasingly aggressive therapies that block VEGF could cause damage in treating eye diseases. Scientists discovered inhibiting anti-VEGF might have a harmful effect on the tissue responsible for producing the fluid that bathes the eye, medically termed the ciliary body.

"Very little is known about the factors that regulate the integrity and function of this tissue [the ciliary body] in the adult," said author Patricia A. D'Amore, PhD, of Schepens Eye Research Institute/Massachusetts Eye and Ear. "Our finding indicates that VEGF-A is at least one of the molecules that play a role in keeping the ciliary body healthy and functioning properly."

In the study, Expression and role of VEGF-A in the Ciliary Body, investigators simulated the VEGF-A activity in adult mice and found that blocking the protein decreased the intraocular pressure, an unexpected side effect that impaired the ciliary body.

Several anti-VEGF-A therapies are currently being widely and successfully used for the treatment of eye diseases like wet macular degeneration, diabetic macular edema and retinopathy of prematurity. D'Amore agrees that there is no evidence to indicate that the manner in which these drugs are being administered interferes with the ciliary body. "However, there is a move toward developing methods to continuously deliver anti-VEGF to the eye and to have drugs that are more potent inhibitors of VEGF," she said. "I would be concerned that more aggressive VEGF inhibition in the eye would have deleterious effects on the ciliary body."

The research team's investigation of anti-VEGF-A on the ciliary body was the result of prior studies that found blocking VEGF can lead to the degeneration of capillary beds, particularly capillaries that have specializations called fenestrations like the ones found in the ciliary body. These include whole body VEGF bl
'/>"/>

Contact: Katrina Norfleet
knorfleet@arvo.org
240-221-2924
Association for Research in Vision and Ophthalmology
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Study Suggests Treating Dyslexia Before Kids Learn to Read
2. New standards for treating traumatic shoulder injuries to improve patient care
3. Treating childhood obesity: A family affair
4. Unique physiology key to diagnosing and treating diabetes in Asian populations
5. Studies See Advances in Detecting, Treating Pancreatic Cancer
6. 1 size doesnt fit all when treating blood pressure in people with diabetes, VA/U-M study suggests
7. Nanomedicines promise fewer side effects in treating cancer
8. Mount Sinai researchers develop a multi-target approach to treating tumors
9. A non-antibiotic approach for treating urinary tract infections
10. UT Southwestern study shows treating diabetes early, intensively is best strategy
11. Researchers report success in treating autism spectrum disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... NY (PRWEB) May 24, 2013 The ... Cellular Dynamics International (CDI) exclusive license rights to ... and regenerative medicine applications. These cells are capable of ... heart, including cardiomyocytes, endothelial cells, and vascular smooth muscle ... therapeutic for damaged heart tissue. , The original agreement ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 On May ... seventh commencement ceremony of American University of Antigua ... in Lincoln Center. , This was the largest graduating ... ceremonies Dick Woodward, AUA’s Senior Vice President for Enrollment ... and Dr. Reza Sanii, Associate Dean of Students and ...
(Date:5/24/2013)... The creative flair and design talent of graduating ... of Textiles and Clothing (ITC) have won applause from ... on 22 May at The Mira Hong Kong. ... students, various knitwear producers and yarn suppliers, the annual ... outfits from 20 graduating students majoring in knitwear design. ...
(Date:5/24/2013)... HealthDay Reporter , , THURSDAY, May 23 (HealthDay News) ... than adults, with signs of serious complications seen just ... "Based on the latest results, it seems like ... Dr. Jane Chiang, senior vice president of medical affairs ... are appearing faster, and it appears to be at ...
(Date:5/24/2013)... News) -- Certain statins -- the widely used ... developing type 2 diabetes, a new study suggests. ... atorvastatin (brand name Lipitor), rosuvastatin (Crestor) and simvastatin ... almost 500,000 Ontario residents, researchers in Canada found ... low in patients prescribed statins. Still, people taking ...
Breaking Medicine News(10 mins):Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 2Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 3Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 4Health News:AUA Celebrates Seventh Annual Commencement Ceremony 2Health News:PolyU Stages Knitwear Fashion Show 2Health News:Type 2 Diabetes Progresses Faster in Kids, Study Finds 2Health News:Type 2 Diabetes Progresses Faster in Kids, Study Finds 3Health News:Could Statins Raise Diabetes Risk? 2Health News:Could Statins Raise Diabetes Risk? 3
... a prestigious international healthcare and wellness center, will implement the ... Cypress Communications®. , ... Atlanta, GA ... healthcare and wellness center, will implement the C4 IP™ ...
... resident M. Michael Wolfe, MD, chief of the Gastroenterology ... research professor of physiology and biophysics at Boston University ... Top Doctors by Castle Connolly Medical Ltd. , The ... medical care, is a trusted and authoritative resource for ...
... been diagnosed with panic attacks or panic disorder have ... suffering a heart attack than the normal population, with ... published in Europe,s leading cardiology journal, the European ... , The study found that people who were younger ...
... WASHINGTON -- The U.S. Environmental Protection Agency should examine ... cause adverse health effects in humans, says a new ... this analysis, called a cumulative risk assessment, should consider ... effects as phthalates, instead of focusing on chemicals that ...
... prescribed for men with chronic prostatitis, a painful disorder ... significantly reduce symptoms in recently diagnosed men who had ... a clinical trial sponsored by the National Institute of ... the National Institutes of Health (NIH). The study is ...
... people know that how we live our lives effects our ... a healthy lifestyle? Why do health professionals like doctors ... public policy, health services, schools and education, the workplace, the ... support healthier living? For instance, can exercise help with addiction? ...
Cached Medicine News:Health News:MALO CLINIC Avoids Capital Expense and Gains Scalability with Hosted Unified Communications 2Health News:MALO CLINIC Avoids Capital Expense and Gains Scalability with Hosted Unified Communications 3Health News:MALO CLINIC Avoids Capital Expense and Gains Scalability with Hosted Unified Communications 4Health News:Boston University Medical Center gastroenterologist 2Health News:Panic attacks linked to higher risk of heart attacks and heart disease, especially in younger people 2Health News:Panic attacks linked to higher risk of heart attacks and heart disease, especially in younger people 3Health News:EPA should pursue cumulative risk assessment of phthalates and other chemicals 2Health News:EPA should pursue cumulative risk assessment of phthalates and other chemicals 3Health News:Common treatment for chronic prostatitis fails to reduce symptoms 2Health News:New Year starts with focus on healthy living 2Health News:New Year starts with focus on healthy living 3
(Date:5/24/2013)... 2013  An international roster of experts on malignant ... Santa Monica, Calif. , to discuss ... MPM, a rare form of cancer that results from ... lining of the chest. Hosted by UCLA ... 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant ...
(Date:5/24/2013)... , May 24, 2013  Heska Corporation (NASDAQ: HSKA, ... and specialty products, announced today that Dr. Robert ... and Jason Napolitano , executive vice president ... Marcum MicroCap Conference, which is being held May 30, 2013 ... Grand Hyatt Hotel. The Company,s presentation is ...
(Date:5/24/2013)... , May 24, 2013 China Biologic Products, ... leading fully integrated plasma-based biopharmaceutical company in ... recently learned from a public announcement issued by Shanghai ... company listed on Shenzhen Stock Exchange, that on May ... ("Ms. Chan"), one of the shareholders of the ...
Breaking Medicine Technology:International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 2International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 3Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4
... YORK, Nov. 14, 2011 Reportlinker.com announces ... available in its catalogue: ... http://www.reportlinker.com/p0203105/The-Outlook-for-Pharmaceuticals-in-Northern-Europe.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=NoCategory ... to represent a combined pharmaceutical market value ...
... MALVERN, Pa., Nov. 13, 2011 TetraLogic ... mimetic drugs to treat cancer, today announced presentations of ... TL32711 at the 2011 AACR-NCI-EORTC International Conference: Molecular ... nearing completion of a single agent Phase 1 study ...
Cached Medicine Technology:The Outlook for Pharmaceuticals in Northern Europe 2The Outlook for Pharmaceuticals in Northern Europe 3The Outlook for Pharmaceuticals in Northern Europe 4TetraLogic Pharmaceuticals Announces Presentation of Data on Smac Mimetic TL32711 at AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics 2
... Vision® Plus DR Urology System provides a ... the first dedicated digital urology imaging system ... was designed to use optimized geometry and ... intensifier for maximum anatomical coverage and sharper ...
Drew Scientific has been making leading edge, top quality CBC systems for over 15 years.,The Evolution offers all the features of the Excell 16 with the new addition of primary sample tube cap pier...
... ETS™ is a therapeutic, expandable turning surface ... ,INDICATIONS , Prevention and treatment of ... to turn, Large patients using a statuc ... relief surface, Patients whose body weight and ...
... The Maxxis™ 400 is a bariatric ... safety for individuals in the home care ... 1000 lbs. (or combined weight of 2) ... depending on frame size selected , ...
Medicine Products: